AC Immune Total Assets (Quarterly) Trends

AC Immune SA (ACIU)

2.38 -0.03 (-1.24%) USD | NASDAQ | Apr 23, 16:00

2.38 0.00 (0.00%) After-Hours: 20:00

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	217.65M
September 30, 2023	156.28M
June 30, 2023	173.73M
March 31, 2023	185.17M
December 31, 2022	200.55M
September 30, 2022	210.79M
June 30, 2022	227.16M
March 31, 2022	255.10M
December 31, 2021	286.01M
September 30, 2021	217.66M
June 30, 2021	229.20M
March 31, 2021	242.00M
December 31, 2020	273.26M
September 30, 2020	279.05M
June 30, 2020	287.31M
March 31, 2020	300.22M
December 31, 2019	308.85M

Date	Value
September 30, 2019	318.12M
June 30, 2019	303.24M
March 31, 2019	314.24M
December 31, 2018	199.64M
September 30, 2018	212.69M
June 30, 2018	112.81M
March 31, 2018	125.86M
December 31, 2017	135.52M
September 30, 2017	129.22M
June 30, 2017	137.39M
March 31, 2017	144.52M
December 31, 2016	153.41M
September 30, 2016	166.29M
June 30, 2016	105.42M
March 31, 2016	76.21M
December 31, 2015	80.87M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

156.28M

Minimum

Sep 2023

318.12M

Maximum

Sep 2019

245.86M

Average

242.00M

Median

Mar 2021

Total Assets (Quarterly) Benchmarks

Roche Holding AG	107.71B
CRISPR Therapeutics AG	2.230B
Addex Therapeutics Ltd	5.526M
NLS Pharmaceutics Ltd	2.270M
Molecular Partners AG	236.15M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly)	26.40M
Shareholders Equity (Quarterly)	191.25M
Current Ratio	9.219